Executive Pascal Soriot News Today

AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver highly potent cancer-killing agents....

The facility, which will be the drugmaker's first end-to-end ADC production site, will be supported by the Singapore Economic Development Board. The company did not provide details on the possible financial incentives from the Singapore government. London-listed AstraZeneca has been expanding into markets like China, Indonesia and India over the past few years in an effort to widen its supply chain.

AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter. Shares in AstraZeneca rose 5.2% to 11,942.00 pence...

AstraZeneca Plc’s AZN Chief Executive Pascal Soriot says the company achieved a significant milestone by reaching a sales target of $45 billion by 2023, a…

By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it...

THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index. The FTSE 100 index opened up 3.58 points at 7,632.33. The FTSE...

By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it reported fourth-quarter results with...

Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings. Chinese consumer prices fell in January at their quickest rate in more than 14 years, data...

AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled. The Cambridge, England-based pharmaceutical company said in the...

By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it...